ABOUT CASTLEMAN’S DISEASE
The Castleman Disease Collaborative Network (CDCN)
https://cdcn.org
National Institutes of Health, Genetic and Rare Disease Information Center:
Multicentric Castleman disease:
https://rarediseases.info.nih.gov/diseases/9644/multicentric-castleman-disease
ABOUT SYLVANT®
European Medicines Agency, SYLVANT® overview and product information:
https://www.ema.europa.eu/en/medicines/human/EPAR/sylvant
ABOUT EUSA PHARMA
EUSA Pharma, including local contact details for medical information:
https://www.eusapharma.com/
© 2020 EUSA Pharma
Date of prep: October 2020
GL-SIL-2000113
This medicinal product is subject to additional monitoring.
Adverse events to medicinal products should be reported.
Reporting forms and information can be found at your local health authority website.
To report a potential adverse event with an EUSA product please send an email to safety@eusapharma.com.
This website is developed and funded by EUSA for healthcare professionals only.
This website will not collect any personal or private information.
© 2020 EUSA Pharma - Registered in England No. 9329429
Registered office: Breakspear Park, Breakspear Way, Hemel Hempstead, Hertfordshire, HP2 4TZ